G protein-coupled modulators (GlaxoSmithKline)

N/A

Report date: 2025/03/20 15:39:10
NME

Base Information

Drug NameG protein-coupled modulators (GlaxoSmithKline)
Drug Alias Name5-HT modulators (GlaxoSmithKline)delta opioid ligands (GlaxoSmithKline)adenosine A1 agonists (GlaxoSmithKline)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionδ-opioid receptor modulatorsAdenosine A1 receptor agonistsSerotonin (5-HT) receptor modulators
TargetsSerotonin (5-HT) receptorAdenosine A1 receptorδ-opioid receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A